Listen for Patients Worried About Cancer Risk With Blood Pressure Meds

January 2019

Questions are cropping up about whether blood pressure meds cause cancer...because of a laundry list of recalls and media reports.

Contamination with a probable carcinogen is leading to ongoing recalls with valsartan products.

Now patients are also hearing that some BP meds themselves are linked to cancer...NOT because of a contaminant.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter Canada includes:

12 issues every year, with brief articles about new meds and hot topics
120+ CE courses, including the popular CE-in-the-Letter
Helpful, in-depth Technician Tutorials
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

Practice More Payers Will Recognize Your Pharmacy's Value in Improving Patient Care
Insurance Work Through "Step-Therapy" Rejections Efficiently
Medication Errors Prevent Mix-Ups Between Lamotrigine and Labetalol
Eczema Think of Fucibet as an Alternative to Fucidin H for Infected Eczema
Antihypertensives Listen for Patients Worried About Cancer Risk With Blood Pressure Meds
Antiarrhythmics Keep Patients Taking Amiodarone Safe
Supplements Be Ready for Questions About Eye Supplements for Blue Light
Oral Health Help Patients With Non-Opioid Options for Dental Pain
Opioids Include the Probuphine Implant in Patient Profiles
MRSA Don't Be Surprised to See Mupirocin Used Intranasally for MRSA Decolonization